{"id":"https://openalex.org/W2005144285","doi":"https://doi.org/10.1179/1120009x12z.00000000015","title":"Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistantPseudomonas aeruginosain Riyadh, Saudi Arabia","display_name":"Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistantPseudomonas aeruginosain Riyadh, Saudi Arabia","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2005144285","doi":"https://doi.org/10.1179/1120009x12z.00000000015","mag":"2005144285","pmid":"https://pubmed.ncbi.nlm.nih.gov/22546765"},"language":"en","primary_location":{"id":"doi:10.1179/1120009x12z.00000000015","doi":"https://doi.org/10.1179/1120009x12z.00000000015","is_oa":false,"landing_page_url":"https://doi.org/10.1179/1120009x12z.00000000015","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005144285"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082523652","display_name":"Mohamed Hamed Al-Agamy","orcid":"https://orcid.org/0000-0001-9868-0355","observed_orcids":["https://orcid.org/0000-0001-9868-0355"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["EG","SA"],"is_corresponding":true,"raw_author_name":"Mohamed H Al-Agamy","raw_affiliation_strings":["Pharmaceutics and Microbiology Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. elagamy71@yahoo.com","Microbiology and Immunology DepartmentFaculty of Pharmacy, Al-Azhar University, Cairo, Egypt","Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics and Microbiology Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. elagamy71@yahoo.com","institution_ids":["https://openalex.org/I28022161"]},{"raw_affiliation_string":"Microbiology and Immunology DepartmentFaculty of Pharmacy, Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]},{"raw_affiliation_string":"Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103219461","display_name":"Atef M. Shibl","orcid":"https://orcid.org/0009-0007-8021-1973","observed_orcids":["https://orcid.org/0009-0007-8021-1973"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Atef M Shibl","raw_affiliation_strings":["Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112133449","display_name":"Abdulkader F. Tawfik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdulkader F Tawfik","raw_affiliation_strings":["Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics and Microbiology DepartmentCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109867058","display_name":"Noura A Elkhizzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335369389","display_name":"Riyadh Armed Forces Hospital","ror":"https://ror.org/00mtny680","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I1335369389"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Noura A Elkhizzi","raw_affiliation_strings":["Microbiology DepartmentArmed Forces Hospital, Riyadh, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microbiology DepartmentArmed Forces Hospital, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I1335369389"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072423246","display_name":"David M. Livermore","orcid":"https://orcid.org/0000-0002-9856-3703","observed_orcids":["https://orcid.org/0000-0002-9856-3703"]},"institutions":[{"id":"https://openalex.org/I1118541","display_name":"University of East Anglia","ror":"https://ror.org/026k5mg93","country_code":"GB","type":"education","lineage":["https://openalex.org/I1118541"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David M Livermore","raw_affiliation_strings":["Department of Medicine University of East Anglia, Norwich, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine University of East Anglia, Norwich, UK","institution_ids":["https://openalex.org/I1118541"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5082523652"],"corresponding_institution_ids":["https://openalex.org/I184834183","https://openalex.org/I28022161"],"apc_list":null,"apc_paid":null,"fwci":1.8973,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.8257488,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"24","issue":"2","first_page":"97","last_page":"100"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12824","display_name":"Infections and bacterial resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10419","display_name":"Pharmaceutical and Antibiotic Environmental Impacts","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2310","display_name":"Pollution"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.972000002861023},{"id":"https://openalex.org/keywords/ceftazidime-resistance","display_name":"ceftazidime resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.996999979019165},{"id":"https://openalex.org/keywords/metallo-beta-lactamase","display_name":"metallo-beta-lactamase","score":1.0},{"id":"https://openalex.org/keywords/vim-1","display_name":"VIM-1","score":0.6970000267028809},{"id":"https://openalex.org/keywords/ges-1","display_name":"GES-1","score":0.8579999804496765},{"id":"https://openalex.org/keywords/veb","display_name":"VEB","score":0.7990000247955322},{"id":"https://openalex.org/keywords/oxa-10","display_name":"OXA-10","score":0.8659999966621399},{"id":"https://openalex.org/keywords/beta-lactamase-genes","display_name":"beta-lactamase genes","score":0.7039999961853027},{"id":"https://openalex.org/keywords/colistin-susceptibility","display_name":"colistin susceptibility","score":0.7049999833106995},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.7429999709129333},{"id":"https://openalex.org/keywords/disease-outbreaks","display_name":"outbreak","score":0.42100000381469727},{"id":"https://openalex.org/keywords/riyadh","display_name":"Riyadh","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.9161996841430664},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.8146462440490723},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7395866513252258},{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.6573498249053955},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5721186995506287},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.479924738407135},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.46139833331108093},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.1611042022705078},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0783759355545044}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001618","descriptor_name":"beta-Lactamases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D001618","descriptor_name":"beta-Lactamases","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D012529","descriptor_name":"Saudi Arabia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1179/1120009x12z.00000000015","doi":"https://doi.org/10.1179/1120009x12z.00000000015","is_oa":false,"landing_page_url":"https://doi.org/10.1179/1120009x12z.00000000015","pdf_url":null,"source":{"id":"https://openalex.org/S127202688","display_name":"Journal of Chemotherapy","issn_l":"1120-009X","issn":["1120-009X","1973-9478"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chemotherapy","raw_type":"journal-article"},{"id":"pmid:22546765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22546765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chemotherapy (Florence, Italy)","raw_type":"Journal Article"},{"id":"pmh:oai:ueaeprints.uea.ac.uk:41718","doi":null,"is_oa":false,"landing_page_url":"https://ueaeprints.uea.ac.uk/id/eprint/41718/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400384","display_name":"UEA Digital Repository (University of East Anglia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1118541","host_organization_name":"University of East Anglia","host_organization_lineage":["https://openalex.org/I1118541"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W611976593","https://openalex.org/W1766021674","https://openalex.org/W1969201253","https://openalex.org/W1989221530","https://openalex.org/W1996207607","https://openalex.org/W2001552676","https://openalex.org/W2028733093","https://openalex.org/W2031103265","https://openalex.org/W2034225270","https://openalex.org/W2103592709","https://openalex.org/W2104172130","https://openalex.org/W2115005019","https://openalex.org/W2123898700","https://openalex.org/W2125910336","https://openalex.org/W2128416861","https://openalex.org/W2141888371","https://openalex.org/W2160510201","https://openalex.org/W2162104953","https://openalex.org/W2167789296","https://openalex.org/W2168484428","https://openalex.org/W2171000901"],"related_works":["https://openalex.org/W2090200927","https://openalex.org/W1498510126","https://openalex.org/W2134276906","https://openalex.org/W3126679161","https://openalex.org/W1969201253","https://openalex.org/W4399270753","https://openalex.org/W4220983090","https://openalex.org/W2162541362","https://openalex.org/W2151678551"],"abstract_inverted_index":{"We":[0],"investigated":[1],"the":[2,29,138,160,165],"extended-spectrum":[3],"(ESBLs)":[4],"and":[5,38,43,57,88,94,102,130,133,164,178],"metallo-beta-lactamases":[6],"(MBLs)":[7],"among":[8],"Pseudomonas":[9],"aeruginosa":[10,23,66,173],"isolates":[11,24,67,126],"in":[12,33,99,114,154,157,162,171],"Saudi":[13],"Arabia.":[14],"Disc":[15],"susceptibility":[16],"testing":[17,37],"was":[18,112,140],"performed":[19],"on":[20,47],"200":[21],"P.":[22,65,172],"collected":[25],"during":[26],"2010":[27],"at":[28],"Armed":[30],"Forces":[31],"Hospital":[32],"Riyadh,":[34],"with":[35,72],"MIC":[36],"phenotypic":[39],"screening":[40],"for":[41,55],"ESBLs":[42,56],"MBLs":[44,58],"carried":[45],"out":[46],"those":[48],"found":[49,98],"to":[50,75,159,176],"be":[51],"ceftazidime":[52,69,169],"resistant.":[53],"Genes":[54],"were":[59,68,97],"sought":[60],"by":[61,143],"PCR.":[62],"Thirty-nine":[63],"(19.5%)":[64],"resistant,":[70],"mostly":[71],"considerable":[73],"resistance":[74,170],"other":[76],"antibiotics":[77],"except":[78],"colistin.":[79],"Twenty-three":[80],"of":[81,105,149],"these":[82],"39":[83],"(59%)":[84],"appeared":[85],"ESBL":[86],"positive":[87],"16":[89,116],"(41%)":[90],"had":[91,127],"MBLs.":[92],"bla(VEB),":[93,121],"bla(GES)":[95],"genes":[96],"20":[100],"(86.95%),":[101],"5":[103],"(21.74%)":[104],"23":[106],"ESBL-positive":[107],"isolates,":[108],"respectively":[109],"whilst":[110],"bla(VIM)":[111,122],"detected":[113],"all":[115],"MBL-producers.":[117],"bla(OXA-10-like)":[118],"often":[119,153],"accompanied":[120],"or":[123],"bla(GES).":[124],"Several":[125],"similar":[128],"antibiogram":[129],"\u03b2-lactamase":[131],"profiles,":[132],"may":[134],"represent":[135],"outbreaks;":[136],"nevertheless,":[137],"collection":[139],"not":[141],"dominated":[142],"any":[144],"single":[145],"clone.":[146],"This":[147],"dominance":[148],"acquired":[150],"ceftazidime-inactivating":[151],"beta-lactamases,":[152],"combination":[155],"is":[156,174],"contrast":[158],"situation":[161],"Europe":[163],"USA,":[166],"where":[167],"most":[168],"attributable":[175],"AmpC":[177],"efflux.":[179]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005144285","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
